Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2020

Open Access 01-12-2020 | Metformin | Research article

Impact of comorbid polycystic ovarian syndrome and gestational diabetes mellitus on pregnancy outcomes: a retrospective cohort study

Authors: Varun Manoharan, Vincent W. Wong

Published in: BMC Pregnancy and Childbirth | Issue 1/2020

Login to get access

Abstract

Background

Gestational diabetes mellitus (GDM) and polycystic ovarian syndrome (PCOS) have been associated with adverse maternal and neonatal outcomes, but the evidence on the impact of coexistent PCOS and GDM is rather limited and inconclusive. We investigated the impact of comorbid PCOS on pregnancy outcomes among women with GDM.

Methods

This retrospective cohort study included women diagnosed with GDM on 75 g oral glucose tolerance test on routine antenatal screening tests at Liverpool Hospital between February 2015 and January 2019. Women were then grouped into those with and without PCOS based on the Rotterdam criteria. The demographic details, clinical data and pregnancy outcomes were compared between the two groups.

Results

Among the 1545 women with GDM included in the study, there were 326 women with PCOS. Women with GDM and PCOS (GDM+PCOS+) were younger (29.5 years vs 31.5 years, p < 0.001), more likely to be primigravidae (31.9% vs 20%, p < 0.001), as well as of Caucasian descent (37.4% vs 21.7%, p < 0.001). PCOS was an independent risk factor for the development of preeclampsia on regression analysis (OR 2.06, p = 0.021). Women with PCOS and GDM had a higher body mass index (31.5 kg/m2 vs 27.7 kg/m2, p < 0.001), significant gestational weight gain (12.6 kg vs 11.5 kg, p = 0.016), and more frequent use of pharmacotherapies to manage their GDM (57.7% vs 45.2%, p < 0.001). There was no statistically significant difference in the rates of adverse neonatal outcomes in both the groups.

Conclusion

Among women with GDM, PCOS was an independent risk factor for the development of preeclampsia and significant gestational weight gain, warranting vigilant monitoring of blood pressure, blood glucose levels and body weight, and implementing timely interventions to improve obstetric and neonatal outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–51.PubMedCrossRef March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–51.PubMedCrossRef
2.
go back to reference Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.PubMedPubMedCentralCrossRef Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.PubMedPubMedCentralCrossRef
3.
go back to reference Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
4.
go back to reference Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes. 2012;61(9):2369–74.PubMedPubMedCentralCrossRef Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes. 2012;61(9):2369–74.PubMedPubMedCentralCrossRef
5.
go back to reference Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141–6.PubMedCrossRef Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141–6.PubMedCrossRef
6.
go back to reference Legro RS, Gnatuk CL, Kunselman AR, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab. 2005;90:3236–42.PubMedCrossRef Legro RS, Gnatuk CL, Kunselman AR, Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab. 2005;90:3236–42.PubMedCrossRef
7.
go back to reference Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(2):226–9.PubMedCrossRef Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 2001;16(2):226–9.PubMedCrossRef
8.
go back to reference Rees DA, Jenkins-Jones S, Morgan CL. Contemporary reproductive outcomes for patients with polycystic ovary syndrome: a retrospective observational study. J Clin Endocrinol Metab. 2016;101:1664–72.PubMedPubMedCentralCrossRef Rees DA, Jenkins-Jones S, Morgan CL. Contemporary reproductive outcomes for patients with polycystic ovary syndrome: a retrospective observational study. J Clin Endocrinol Metab. 2016;101:1664–72.PubMedPubMedCentralCrossRef
9.
go back to reference Mustaniemi S, Vääräsmäki M, Eriksson JG, Gissler M, Laivuori H, Ijäs H, et al. Polycystic ovary syndrome and risk factors for gestational diabetes. Endocrine Connect. 2018;7(7):859–69.CrossRef Mustaniemi S, Vääräsmäki M, Eriksson JG, Gissler M, Laivuori H, Ijäs H, et al. Polycystic ovary syndrome and risk factors for gestational diabetes. Endocrine Connect. 2018;7(7):859–69.CrossRef
10.
go back to reference Turhan NO, Seckin NC, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet. 2003;81:163–8.PubMedCrossRef Turhan NO, Seckin NC, Aybar F, Inegol I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet. 2003;81:163–8.PubMedCrossRef
11.
go back to reference Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod. 2003;18:1438–41.PubMedCrossRef Haakova L, Cibula D, Rezabek K, Hill M, Fanta M, Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod. 2003;18:1438–41.PubMedCrossRef
12.
go back to reference Barbour LA, McCurdy CE, Herandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in Normal pregnancy and gestational diabetes. Diab Care. 2007;30(2):S112–9.CrossRef Barbour LA, McCurdy CE, Herandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in Normal pregnancy and gestational diabetes. Diab Care. 2007;30(2):S112–9.CrossRef
13.
go back to reference Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Rev. 1997;18(6):774–800. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Rev. 1997;18(6):774–800.
14.
go back to reference Harlev A, Witnitzer A. New insights into glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep. 2010;10(3):242–7.PubMedCrossRef Harlev A, Witnitzer A. New insights into glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep. 2010;10(3):242–7.PubMedCrossRef
15.
go back to reference HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–9.CrossRef HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–9.CrossRef
16.
go back to reference von Katterfeld B, Li J, McNamara B, Langridge AT. Maternal and neonatal outcomes associated with gestational diabetes in women from culturally and linguistically diverse backgrounds in Western Australia. Diabet Med. 2012;29:372–7.CrossRef von Katterfeld B, Li J, McNamara B, Langridge AT. Maternal and neonatal outcomes associated with gestational diabetes in women from culturally and linguistically diverse backgrounds in Western Australia. Diabet Med. 2012;29:372–7.CrossRef
17.
go back to reference Doherty DA, Newnham JP, Bower C. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397–406.PubMedCrossRef Doherty DA, Newnham JP, Bower C. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397–406.PubMedCrossRef
18.
go back to reference Kollmann M, Klaritsch P, Martins WP. Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod. 2015;30(10):2396–403.PubMedCrossRef Kollmann M, Klaritsch P, Martins WP. Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod. 2015;30(10):2396–403.PubMedCrossRef
19.
go back to reference Foroozanfard F, Moosaavi SGA, Mansouri F, Bazarganipour F. Obstetric and neonatal outcome in PCOS with gestational diabetes mellitus. J Fam Reprod Health. 2014;8(1):7–12. Foroozanfard F, Moosaavi SGA, Mansouri F, Bazarganipour F. Obstetric and neonatal outcome in PCOS with gestational diabetes mellitus. J Fam Reprod Health. 2014;8(1):7–12.
20.
go back to reference Alshammari A, Hanley A, Ni A, Tomlinson G, Feig DS. Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes? J Metrnal-Fetal Neon Med. 2010;23(6):545–9. Alshammari A, Hanley A, Ni A, Tomlinson G, Feig DS. Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes? J Metrnal-Fetal Neon Med. 2010;23(6):545–9.
21.
go back to reference Palomba S, de Wilde MA, Falbo A, Koster MPH, Sala GBL, Fauser BCJM. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–92.PubMedCrossRef Palomba S, de Wilde MA, Falbo A, Koster MPH, Sala GBL, Fauser BCJM. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–92.PubMedCrossRef
22.
go back to reference Mahomed K, Williams MA, Woelk GB. Risk factors for pre-Eclampsia among Zimbabwean women - maternal arm circumference and other anthropometric measures of obesity. Paediatr Perinat Epidemiol. 1998;12:253–62.PubMedCrossRef Mahomed K, Williams MA, Woelk GB. Risk factors for pre-Eclampsia among Zimbabwean women - maternal arm circumference and other anthropometric measures of obesity. Paediatr Perinat Epidemiol. 1998;12:253–62.PubMedCrossRef
23.
go back to reference Nankervis A, McIntyre HD, Moses R, Ross GP, Callway L, Porter C, et al. ADIPS consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia. NSW: Australasian Diabetes in Pregnancy Society; 2014. Nankervis A, McIntyre HD, Moses R, Ross GP, Callway L, Porter C, et al. ADIPS consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia. NSW: Australasian Diabetes in Pregnancy Society; 2014.
24.
go back to reference Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world- a growing challenge. N Engl J Med. 2007;356:213–5.PubMedCrossRef Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world- a growing challenge. N Engl J Med. 2007;356:213–5.PubMedCrossRef
25.
go back to reference Hauger MS, Gibbons L, Vik T, Belizan JM. Prepregnancy weight status and the risk of adverse pregnancy outcome. Acta Obstet Gynecol Scand. 2008;87:953–9.PubMedCrossRef Hauger MS, Gibbons L, Vik T, Belizan JM. Prepregnancy weight status and the risk of adverse pregnancy outcome. Acta Obstet Gynecol Scand. 2008;87:953–9.PubMedCrossRef
27.
go back to reference Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–83.PubMedCrossRef Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–83.PubMedCrossRef
28.
go back to reference Mañé L, Flores-Le Roux JA, Benaiges D, Rodríguez M, Marcelo I, Chillarón JJ, et al. Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort. J Clin Endocrinol Metab. 2018;102(2):390–7. Mañé L, Flores-Le Roux JA, Benaiges D, Rodríguez M, Marcelo I, Chillarón JJ, et al. Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort. J Clin Endocrinol Metab. 2018;102(2):390–7.
29.
go back to reference Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynaecol. 1998;179(4):1032–7.CrossRef Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynaecol. 1998;179(4):1032–7.CrossRef
30.
go back to reference Joham AE, Palomba S, Hart R. Polycystic ovary syndrome, obesity, and pregnancy. Semin Reprod Med. 2016;34(2):93–101.PubMedCrossRef Joham AE, Palomba S, Hart R. Polycystic ovary syndrome, obesity, and pregnancy. Semin Reprod Med. 2016;34(2):93–101.PubMedCrossRef
31.
32.
go back to reference Randon PA, MacMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol. 1999;94:194–7. Randon PA, MacMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol. 1999;94:194–7.
33.
go back to reference Yu H, Chen H, Rao D, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2016;95(51):e4863.PubMedPubMedCentralCrossRef Yu H, Chen H, Rao D, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2016;95(51):e4863.PubMedPubMedCentralCrossRef
34.
go back to reference Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med. 2009;26:798–802.PubMedCrossRef Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med. 2009;26:798–802.PubMedCrossRef
35.
go back to reference Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. MiG trial investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003–15.PubMedCrossRef Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. MiG trial investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003–15.PubMedCrossRef
Metadata
Title
Impact of comorbid polycystic ovarian syndrome and gestational diabetes mellitus on pregnancy outcomes: a retrospective cohort study
Authors
Varun Manoharan
Vincent W. Wong
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2020
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-03175-5

Other articles of this Issue 1/2020

BMC Pregnancy and Childbirth 1/2020 Go to the issue